Biotech Values

[DewDiligence]

MNOV acquires AVGN for $1.24/sh:

http://finance.yahoo.com/news/MediciNova-and-Avigen-Enter-pz-843568777.html?x=0&.v=1

This is a different twist insofar as there is no premium to the market price—the $1.24 buyout price is a 7% discount to AVGN’s closing price on Aug 20. There’s a contingent payment in the merger agreement that could raise the total consideration to $1.44, however.